OKUR
OnKure Therapeutics, Inc.
Company overview
- Market capitalization
- $111.77M
- Employees
- 45
- Latest publication
- 2026-09-29
About OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 203,000USD | 202,000USD | — | 212,000USD | 212,000USD | 419,000USD | 12,000USD | 12,000USD |
| Gross Profit | -203,000USD | -202,000USD | — | -212,000USD | -212,000USD | -419,000USD | -12,000USD | -12,000USD |
| Research Development | 11,707,000USD | 10,720,000USD | 11,915,000USD | 12,613,000USD | 13,012,000USD | 37,359,000USD | 892,000USD | 10,752,000USD |
| Selling General Administrative | 3,908,000USD | 3,405,000USD | 3,586,000USD | 3,711,000USD | 3,988,000USD | 3,564,000USD | 3,760,000USD | 3,591,000USD |
| Total Operating Expenses | 15,412,000USD | 14,125,000USD | 15,501,000USD | 16,324,000USD | 17,000,000USD | 33,795,000USD | 4,660,000USD | 14,343,000USD |
| Operating Income | -15,615,000USD | -14,125,000USD | -15,501,000USD | -16,324,000USD | -17,000,000USD | -33,795,000USD | -4,672,000USD | -14,343,000USD |
| Interest Income | 458,000USD | 628,000USD | 804,000USD | 934,000USD | 1,075,000USD | — | 174,000USD | 230,000USD |
| Net Interest Income | 458,000USD | 622,000USD | 802,000USD | 934,000USD | 1,075,000USD | — | -44,000USD | 204,000USD |
| Income Before Tax | -15,157,000USD | -13,503,000USD | -14,699,000USD | -15,390,000USD | -15,925,000USD | -35,194,000USD | -3,692,000USD | -14,139,000USD |
| Net Income | -15,157,000USD | -13,503,000USD | -14,699,000USD | -15,390,000USD | -15,925,000USD | -35,194,000USD | -3,692,000USD | -14,139,000USD |
| Net Income From Continuing Ops | -15,157,000USD | -13,503,000USD | -14,699,000USD | -15,390,000USD | -15,925,000USD | -35,194,000USD | -3,692,000USD | -14,139,000USD |
| Ebit | -15,615,000USD | -13,497,000USD | -14,697,000USD | -15,390,000USD | -17,000,000USD | -31,782,000USD | -3,692,000USD | -14,113,000USD |
| Ebitda | -15,412,000USD | -13,295,000USD | -14,493,000USD | -15,178,000USD | -16,788,000USD | -31,160,000USD | -3,680,000USD | -13,965,000USD |
| Depreciation And Amortization | 203,000USD | 202,000USD | 204,000USD | 212,000USD | 212,000USD | 622,000USD | 12,000USD | 148,000USD |
| Reconciled Depreciation | 203,000USD | 202,000USD | 204,000USD | 212,000USD | 212,000USD | 622,000USD | -259,000USD | 148,000USD |
| Total Other Income Expense Net | 458,000USD | 622,000USD | 802,000USD | 934,000USD | 1,075,000USD | -1,399,000USD | 980,000USD | 204,000USD |
| Interest Expense | — | 6,000USD | 2,000USD | 0USD | — | — | 218,000USD | 26,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | -7,128,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — | — |
| Cost Of Revenue | 830,000USD | 662,000USD | 560,000USD | 529,000USD | 50,000USD | 37,000USD |
| Gross Profit | -830,000USD | -662,000USD | -560,000USD | -529,000USD | -50,000USD | -37,000USD |
| Research Development | 48,260,000USD | 43,795,000USD | 32,115,000USD | 25,862,000USD | 28,119,000USD | 15,907,000USD |
| Selling General Administrative | 14,690,000USD | 10,591,000USD | 4,819,000USD | 3,904,000USD | — | — |
| Total Operating Expenses | 62,120,000USD | 54,386,000USD | 36,934,000USD | 29,766,000USD | 39,768,000USD | 19,515,000USD |
| Operating Income | -62,950,000USD | -54,386,000USD | -36,934,000USD | -29,766,000USD | -39,818,000USD | -19,552,000USD |
| Interest Income | 3,441,000USD | 2,013,000USD | 1,623,000USD | 254,000USD | — | — |
| Interest Expense | 8,000USD | 300,000USD | 0USD | — | — | — |
| Net Interest Income | 3,433,000USD | 1,713,000USD | 1,623,000USD | 254,000USD | — | — |
| Income Before Tax | -59,517,000USD | -52,673,000USD | -35,311,000USD | -29,512,000USD | -39,770,000USD | -19,465,000USD |
| Net Income | -59,517,000USD | -52,673,000USD | -35,311,000USD | -29,512,000USD | -39,770,000USD | -19,465,000USD |
| Net Income From Continuing Ops | -59,517,000USD | -52,673,000USD | -35,311,000USD | -29,512,000USD | — | — |
| Ebit | -62,950,000USD | -52,373,000USD | -35,311,000USD | -29,766,000USD | -39,770,000USD | -19,465,000USD |
| Ebitda | -62,120,000USD | -51,711,000USD | -34,751,000USD | -29,379,000USD | -39,720,000USD | -19,428,000USD |
| Depreciation And Amortization | 830,000USD | 662,000USD | 560,000USD | 387,000USD | 50,000USD | 37,000USD |
| Reconciled Depreciation | 830,000USD | 662,000USD | 560,000USD | 387,000USD | — | — |
| Total Other Income Expense Net | 3,433,000USD | 1,713,000USD | 1,623,000USD | 254,000USD | 48,000USD | 87,000USD |
| Unclassified Operating Expenses | — | — | — | — | 11,649,000USD | 3,608,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 179,353,000USD | 198,694,000USD | 62,117,000USD | 72,835,000USD | 86,070,000USD | 99,882,000USD | 114,907,000USD | 77,645,000USD |
| Cash And Equivalents | 166,502,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 177,677,000USD | 197,482,000USD | 60,839,000USD | 71,526,000USD | 84,552,000USD | 98,172,000USD | 113,003,000USD | 76,999,000USD |
| Other Current Assets | 1,291,000USD | 5,376,000USD | 1,789,000USD | 1,195,000USD | 1,178,000USD | 1,511,000USD | 2,242,000USD | 331,000USD |
| Other Non Current Assets | 401,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 7,245,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 6,643,000USD | 14,329,000USD | 5,921,000USD | 6,247,000USD | 7,597,000USD | 8,785,000USD | 10,530,000USD | 3,248,000USD |
| Other Non Current Liabilities | 12,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 172,108,000USD | 184,353,000USD | 56,184,000USD | 66,428,000USD | 78,166,000USD | 90,648,000USD | 103,828,000USD | 74,018,000USD |
| Total Equity Including Noncontrolling Interest | 172,108,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,275,000USD | 807,000USD | 1,005,000USD | 1,205,000USD | 1,402,000USD | 1,601,000USD | 1,795,000USD | 499,000USD |
| Accounts Payable | 1,999,000USD | 11,022,000USD | 1,433,000USD | 1,290,000USD | 2,381,000USD | 2,344,000USD | 2,968,000USD | 237,000USD |
| Short Term Debt | 336,000USD | 409,000USD | 549,000USD | 567,000USD | 556,000USD | 546,000USD | 536,000USD | 286,000USD |
| Retained Earnings | -244,744,000USD | -229,398,000USD | -214,241,000USD | -200,738,000USD | -186,039,000USD | -170,649,000USD | -154,724,000USD | -235,953,000USD |
| Accumulated Other Comprehensive Income | -13,000USD | — | — | — | — | — | — | 2,000USD |
| Total Liab | — | 14,341,000USD | 5,933,000USD | 6,407,000USD | 7,904,000USD | 9,234,000USD | 11,079,000USD | 3,627,000USD |
| Other Current Liab | — | 2,898,000USD | 3,939,000USD | 4,390,000USD | 4,660,000USD | 5,895,000USD | 7,026,000USD | 2,725,000USD |
| Common Stock | — | 4,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | — |
| Capital Stock | — | 4,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 0USD |
| Cash | — | 192,106,000USD | 59,050,000USD | 70,331,000USD | 83,374,000USD | 96,661,000USD | 110,761,000USD | 60,689,000USD |
| Cash And Short Term Investments | — | 192,106,000USD | 59,050,000USD | 70,331,000USD | 83,374,000USD | 96,661,000USD | 110,761,000USD | 76,668,000USD |
| Net Debt | — | -191,697,000USD | -58,501,000USD | -69,644,000USD | -82,551,000USD | -95,706,000USD | -109,676,000USD | -60,024,000USD |
| Short Long Term Debt Total | — | 409,000USD | 549,000USD | 687,000USD | 823,000USD | 955,000USD | 1,085,000USD | 665,000USD |
| Property Plant Equipment Gross | — | 2,371,000USD | 2,466,000USD | 2,565,000USD | 2,756,000USD | 2,838,000USD | 2,914,000USD | 499,000USD |
| Common Stock Shares Outstanding | — | 13,674,577shares | 13,515,915shares | 13,509,080shares | 13,509,080shares | 13,424,335shares | 13,339,417shares | 13,339,417shares |
| Non Current Assets Total | — | 1,212,000USD | 1,278,000USD | 1,309,000USD | 1,518,000USD | 1,710,000USD | 1,904,000USD | 646,000USD |
| Non Current Liabilities Total | — | 12,000USD | 12,000USD | 160,000USD | 307,000USD | 449,000USD | 549,000USD | 379,000USD |
| Non Current Liabilities Other | — | 12,000USD | 12,000USD | 40,000USD | 40,000USD | 40,000USD | — | — |
| Non Currrent Assets Other | — | 405,000USD | 273,000USD | 104,000USD | 116,000USD | 109,000USD | 109,000USD | 147,000USD |
| Net Working Capital | — | 183,153,000USD | 54,918,000USD | 65,279,000USD | 76,955,000USD | 89,387,000USD | 102,473,000USD | 73,751,000USD |
| Unclassified Equity | — | 413,743,000USD | 270,423,000USD | 267,164,000USD | 264,203,000USD | 261,295,000USD | 258,550,000USD | 309,969,000USD |
| Short Term Investments | — | — | — | — | — | — | — | 15,979,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 62,117,000USD | 114,907,000USD | 35,734,000USD | 15,999,000USD | 154,024,000USD | 55,221,000USD |
| Other Current Assets | 1,789,000USD | 2,242,000USD | 3,890,000USD | 2,080,000USD | 6,064,000USD | 1,412,000USD |
| Total Liab | 5,933,000USD | 11,079,000USD | 137,576,000USD | 70,417,000USD | 6,813,000USD | 97,336,000USD |
| Total Stockholder Equity | 56,184,000USD | 103,828,000USD | -101,842,000USD | -54,418,000USD | 147,211,000USD | -42,115,000USD |
| Other Current Liab | 3,939,000USD | 7,026,000USD | 3,660,000USD | 2,871,000USD | 6,202,000USD | 4,580,000USD |
| Common Stock | 1,000USD | 1,000USD | — | 1,000USD | 3,000USD | 1,000USD |
| Capital Stock | 1,000USD | 1,000USD | 0USD | 1,000USD | — | — |
| Retained Earnings | -214,241,000USD | -154,724,000USD | -102,051,000USD | -57,074,000USD | -84,728,000USD | -44,958,000USD |
| Cash | 59,050,000USD | 110,761,000USD | 29,876,000USD | 11,543,000USD | 124,660,000USD | 53,613,000USD |
| Cash And Short Term Investments | 59,050,000USD | 110,761,000USD | 29,876,000USD | 11,543,000USD | 147,670,000USD | 53,613,000USD |
| Total Current Assets | 60,839,000USD | 113,003,000USD | 33,766,000USD | 13,623,000USD | 153,734,000USD | 55,025,000USD |
| Total Current Liabilities | 5,921,000USD | 10,530,000USD | 7,285,000USD | 5,542,000USD | 6,202,000USD | 4,580,000USD |
| Net Debt | -58,501,000USD | -109,676,000USD | -29,202,000USD | -10,906,000USD | -124,660,000USD | 39,107,000USD |
| Short Term Debt | 549,000USD | 536,000USD | 208,000USD | 151,000USD | — | — |
| Short Long Term Debt Total | 549,000USD | 1,085,000USD | 674,000USD | 637,000USD | — | 92,720,000USD |
| Accounts Payable | 1,433,000USD | 2,968,000USD | 3,417,000USD | 2,520,000USD | — | — |
| Property Plant Equipment Net | 1,005,000USD | 1,795,000USD | 1,910,000USD | 2,047,000USD | 212,000USD | 69,000USD |
| Property Plant Equipment Gross | 2,466,000USD | 2,914,000USD | 2,575,000USD | 2,295,000USD | — | — |
| Common Stock Shares Outstanding | 13,515,915shares | 13,339,417shares | 13,339,417shares | 13,339,417shares | 1,814,348shares | 2,514,819shares |
| Non Current Assets Total | 1,278,000USD | 1,904,000USD | 1,968,000USD | 2,376,000USD | 290,000USD | 196,000USD |
| Non Current Liabilities Total | 12,000USD | 549,000USD | 130,291,000USD | 64,875,000USD | 611,000USD | 92,756,000USD |
| Non Current Liabilities Other | 12,000USD | — | — | — | — | — |
| Non Currrent Assets Other | 273,000USD | 109,000USD | 58,000USD | 329,000USD | 78,000USD | 127,000USD |
| Net Working Capital | 54,918,000USD | 102,473,000USD | 26,481,000USD | 8,081,000USD | — | — |
| Unclassified Equity | 270,423,000USD | 258,550,000USD | — | 2,697,000USD | 231,902,000USD | 2,842,000USD |
| Unclassified Non Current Liabilities | — | — | 130,291,000USD | 64,875,000USD | — | 92,756,000USD |
| Short Term Investments | — | — | — | 81,246,000USD | 23,010,000USD | — |
| Accumulated Other Comprehensive Income | — | — | — | -43,000USD | 34,000USD | — |
| Unclassified Current Assets | — | — | — | -81,246,000USD | — | — |
| Other Assets | — | — | — | — | 1USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -15,157,000USD | -13,503,000USD | -14,699,000USD | -15,390,000USD | -15,925,000USD | -35,194,000USD | -11,556,000USD | -14,139,000USD |
| Depreciation | 203,000USD | 202,000USD | 204,000USD | 212,000USD | 212,000USD | 622,000USD | 155,000USD | 148,000USD |
| Stock Based Compensation | 2,780,000USD | 3,019,000USD | 2,961,000USD | 2,908,000USD | 2,745,000USD | 1,637,000USD | 77,000USD | 1,813,000USD |
| Other Non Cash Items | -764,000USD | 4,000USD | 2,000USD | -1,004,000USD | — | 2,062,000USD | 127,000USD | 1,000USD |
| Change In Working Capital | -764,000USD | -1,234,000USD | -1,505,000USD | -1,004,000USD | -1,037,000USD | 9,858,000USD | 536,000USD | 5,704,000USD |
| Total Cash From Operating Activities | -12,938,000USD | -11,512,000USD | -13,037,000USD | -13,274,000USD | -14,005,000USD | -21,015,000USD | -10,661,000USD | -6,473,000USD |
| Capital Expenditures | -5,000USD | -9,000USD | -6,000USD | -13,000USD | -18,000USD | -50,000USD | -18,000USD | -10,000USD |
| Free Cash Flow | -12,943,000USD | -11,521,000USD | -13,043,000USD | -13,287,000USD | -14,023,000USD | -21,065,000USD | -10,679,000USD | -6,483,000USD |
| Total Cashflows From Investing Activities | -5,000USD | -9,000USD | -6,000USD | -13,000USD | -18,000USD | -45,375,000USD | -18,000USD | -10,000USD |
| Total Cash From Financing Activities | 145,999,000USD | 240,000USD | 0USD | 0USD | -77,000USD | 114,218,000USD | 5,000USD | 5,868,000USD |
| Issuance Of Capital Stock | 145,999,000USD | 0USD | 0USD | 0USD | 0USD | 58,907,000USD | -20,000USD | 10,000USD |
| Change In Cash | 133,056,000USD | -11,281,000USD | -13,043,000USD | -13,287,000USD | -14,100,000USD | 50,072,000USD | -10,674,000USD | -615,000USD |
| Begin Period Cash Flow | 59,050,000USD | 70,331,000USD | 83,374,000USD | 96,661,000USD | 110,761,000USD | 60,689,000USD | 18,633,000USD | 19,248,000USD |
| End Period Cash Flow | 192,106,000USD | 59,050,000USD | 70,331,000USD | 83,374,000USD | 96,661,000USD | 110,761,000USD | 7,959,000USD | 18,633,000USD |
| Other Cashflows From Financing Activities | 145,999,000USD | 240,000USD | — | — | -40,000USD | 55,311,000USD | 2,020,000USD | 5,858,000USD |
| Unclassified Financing Cash Flow | -145,999,000USD | — | — | — | — | — | -1,995,000USD | — |
| Net Borrowings | — | 0USD | 0USD | — | — | — | 0USD | — |
| Investments | — | — | -6,000USD | -13,000USD | -18,000USD | -45,375,000USD | 61,267,000USD | -10,000USD |
| Unclassified Operating Cash Flow | — | — | — | 1,004,000USD | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 67,750,000USD | -17,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | -67,700,000USD | -61,250,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -59,517,000USD | -52,673,000USD | -35,311,000USD | -29,512,000USD | -39,770,000USD | -19,465,000USD |
| Depreciation | 830,000USD | 662,000USD | 560,000USD | 387,000USD | 50,000USD | 37,000USD |
| Stock Based Compensation | 11,633,000USD | 4,530,000USD | 199,000USD | 48,000USD | — | — |
| Other Non Cash Items | 6,000USD | 316,000USD | — | — | 4,537,000USD | 378,000USD |
| Change In Working Capital | -4,780,000USD | -3,952,000USD | 6,000USD | 2,124,000USD | -2,800,000USD | 514,000USD |
| Total Cash From Operating Activities | -51,828,000USD | -51,117,000USD | -34,546,000USD | -26,953,000USD | -37,983,000USD | -18,536,000USD |
| Capital Expenditures | -46,000USD | -52,000USD | -246,000USD | -1,134,000USD | -198,000USD | -24,000USD |
| Free Cash Flow | -51,874,000USD | -51,169,000USD | -34,792,000USD | -28,087,000USD | -38,181,000USD | -18,560,000USD |
| Investments | 0USD | 15,873,000USD | -246,000USD | -1,134,000USD | — | — |
| Total Cashflows From Investing Activities | -46,000USD | 15,873,000USD | -246,000USD | -1,134,000USD | -23,376,000USD | 7,376,000USD |
| Net Borrowings | 0USD | 6,000,000USD | 0USD | — | — | — |
| Total Cash From Financing Activities | 163,000USD | 116,129,000USD | 53,125,000USD | 26,465,000USD | 132,406,000USD | 47,272,000USD |
| Issuance Of Capital Stock | 0USD | 58,907,000USD | 53,848,000USD | 27,840,000USD | — | — |
| Change In Cash | -51,711,000USD | 80,885,000USD | 18,333,000USD | -1,622,000USD | 71,047,000USD | 36,112,000USD |
| Begin Period Cash Flow | 110,761,000USD | 29,876,000USD | 11,543,000USD | 13,165,000USD | 53,613,000USD | 17,501,000USD |
| End Period Cash Flow | 59,050,000USD | 110,761,000USD | 29,876,000USD | 11,543,000USD | 124,660,000USD | 53,613,000USD |
| Other Cashflows From Financing Activities | -40,000USD | 51,222,000USD | 53,060,000USD | 26,125,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | -53,783,000USD | -27,500,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | -44,100,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | 45,234,000USD | -23,178,000USD | 7,400,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.